In a recent development, Dartmouth College is seeking the review of the U.S. Supreme Court over the Federal Circuit’s decision not to renew a vitamin B3 patent. The college had originally defended this patent against Elysium Health in a preliminary Delaware federal lawsuit.
Elysium Health, known for its dietary supplement production, appears to be in conflict with Dartmouth College over the subject patent, causing it to escalate to the level of the U.S. Supreme Court. At present, the Federal Circuit has refused the revival of the vitamin B3 patent, causing potential implications for similar patent-related issues in the wider medical and educational sectors.
Delaware federal suits are known for their strict rulings on legal matters pertaining to patents and trademarks, which makes the case noteworthy on a national legal platform. It remains to be seen how the U.S. Supreme Court reacts to Dartmouth College’s appeal and what impact this could have on future patent disputes in the medical and health supplement industries.
To learn more about the developing situation surrounding the vitamin B3 patent dispute between Dartmouth College and Elysium Health, please consult the original and comprehensive coverage of the case at Law360.